Skip to main content

Endovascular Treatment of Intracranial Stenosis and Vasospasm

  • Chapter
  • First Online:
Handbook of Cerebrovascular Disease and Neurointerventional Technique

Part of the book series: Contemporary Medical Imaging ((CMI))

  • 2247 Accesses

Abstract

This chapter discusses techniques for intracranial angioplasty and stenting for atherosclerotic arterial stenosis, and angioplasty and intra-arterial drug infusion for cerebral vasospasm after aneurysmal SAH. Complication avoidance and management are covered.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  1. Chimowitz MI, Lynn MJ, Derdeyn CP, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011;365:993–1003.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352:1305–16.

    Article  CAS  PubMed  Google Scholar 

  3. Bose A, Hartmann M, Henkes H, et al. A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the wingspan study. Stroke. 2007;38:1531–7.

    Article  CAS  PubMed  Google Scholar 

  4. Fiorella D, Levy EI, Turk AS, et al. US multicenter experience with the wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke. 2007;38:881–7.

    Article  PubMed  Google Scholar 

  5. Gray WA, Yadav JS, Verta P, et al. The CAPTURE registry: predictors of outcomes in carotid artery stenting with embolic protection for high surgical risk patients in the early post-approval setting. Catheter Cardiovasc Interv. 2007;70:1025–33.

    Article  PubMed  Google Scholar 

  6. Topakian R, Strasak AM, Sonnberger M, et al. Timing of stenting of symptomatic carotid stenosis is predictive of 30-day outcome. Eur J Neurol. 2007;14:672–8.

    Article  CAS  PubMed  Google Scholar 

  7. Derdeyn CP, Chimowitz MI, Lynn MJ, et al. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet. 2014;383:333–41.

    Article  PubMed  Google Scholar 

  8. Lutsep HL, Barnwell SL, Larsen DT, et al. Outcome in patients previously on antithrombotic therapy in the SAMMPRIS trial: subgroup analysis. Stroke. 2015;46:775–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Derdeyn CP, Fiorella D, Lynn MJ, et al. Mechanisms of stroke after intracranial angioplasty and stenting in the SAMMPRIS trial. Neurosurgery. 2013;72:777–95. discussion 95

    Article  PubMed  Google Scholar 

  10. Fiorella D, Derdeyn CP, Lynn MJ, et al. Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in stenting and aggressive medical Management for Preventing Recurrent Stroke in intracranial stenosis (SAMMPRIS). Stroke. 2012;43:2682–8.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Zaidat OO, Fitzsimmons BF, Woodward BK, et al. Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial. JAMA. 2015;313:1240–8.

    Article  CAS  PubMed  Google Scholar 

  12. Rohde S, Seckinger J, Hahnel S, Ringleb PA, Bendszus M, Hartmann M. Stent design lowers angiographic but not clinical adverse events in stenting of symptomatic intracranial stenosis - results of a single center study with 100 consecutive patients. Int J Stroke. 2013;8:87–94.

    Article  CAS  PubMed  Google Scholar 

  13. Intracranial Angioplasty & Stenting for Cerebral Atherosclerosis. A position statement of the American Society of Interventional and Therapeutic Neuroradiology, Society of Interventional Radiology, and the American society of neuroradiology. AJNR Am J Neuroradiol. 2005;26:2323–7.

    Google Scholar 

  14. Narrowed Indications for Use for the Stryker Wingspan Stent System: FDA Safety Communication. 2015. at https://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm314600.htm.

  15. Abou-Chebl A, Krieger DW, Bajzer CT, Yadav JS. Intracranial angioplasty and stenting in the awake patient. J Neuroimaging. 2006;16:216–23.

    Article  PubMed  Google Scholar 

  16. Kiyosue H, Okahara M, Yamashita M, Nagatomi H, Nakamura N, Mori H. Endovascular stenting for restenosis of the intracranial vertebrobasilar artery after balloon angioplasty: two case reports and review of the literature. Cardiovasc Intervent Radiol. 2004;27:538–43.

    Article  PubMed  Google Scholar 

  17. Kessler IM, Mounayer C, Piotin M, Spelle L, Vanzin JR, Moret J. The use of balloon-expandable stents in the management of intracranial arterial diseases: a 5-year single-center experience. AJNR Am J Neuroradiol. 2005;26:2342–8.

    PubMed  PubMed Central  Google Scholar 

  18. Wingspanâ„¢ Stent System with Gatewayâ„¢ PTA Balloon Catheter Product In-Service CD. 2005.

    Google Scholar 

  19. Coolong A, Mauri L. Clopidogrel treatment surrounding percutaneous coronary intervention: when should it be started and stopped? Curr Cardiol Rep. 2006;8:267–71.

    Article  PubMed  Google Scholar 

  20. Qureshi AI, Saad M, Zaidat OO, et al. Intracerebral hemorrhages associated with neurointerventional procedures using a combination of antithrombotic agents including abciximab. Stroke. 2002;33:1916–9.

    Article  CAS  PubMed  Google Scholar 

  21. Macdonald RL. Management of cerebral vasospasm. Neurosurg Rev. 2006;29:179–93.

    Article  Google Scholar 

  22. Harrigan MR. Hypertension may be the most important component of hyperdynamic therapy in cerebral vasospasm. Crit Care. 2010;14:151.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Jabbour P, Veznedaroglu E, Liebman K, Rosenwasser RH. Is radiographic ischemia a contraindication for angioplasty in subarachnoid hemorrhage? In: AANS annual meeting. San Francisco: American Association of Neurological Surgeons; 2006.

    Google Scholar 

  24. Mechanical and pharmocologic treatment of vasospasm. AJNR Am J Neuroradiol. 2001;22:26S–7.

    Google Scholar 

  25. Bernardini GL, Mayer SA, Kossoff SB, Hacein-Bey L, Solomon RA, Pile-Spellman J. Anticoagulation and induced hypertension after endovascular treatment for ruptured intracranial aneurysms. Crit Care Med. 2001;29:641–4.

    Article  CAS  PubMed  Google Scholar 

  26. Hoh BL, Nogueira RG, Ledezma CJ, Pryor JC, Ogilvy CS. Safety of heparinization for cerebral aneurysm coiling soon after external ventriculostomy drain placement. Neurosurgery. 2005;57:845–9. discussion-9

    Article  PubMed  Google Scholar 

  27. Raabe A, Gerlach R, Zimmermann M, Seifert V. The risk of haemorrhage associated with early postoperative heparin administration after intracranial surgery. Acta Neurochir. 2001;143:1–7.

    Article  CAS  PubMed  Google Scholar 

  28. Terry A, Zipfel G, Milner E, et al. Safety and technical efficacy of over-the-wire balloons for the treatment of subarachnoid hemorrhage-induced cerebral vasospasm. Neurosurg Focus. 2006;21:E14.

    Article  PubMed  Google Scholar 

  29. Eskridge JM, Song JK. A practical approach to the treatment of vasospasm. AJNR Am J Neuroradiol. 1997;18:1653–60.

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Murayama Y, Song JK, Uda K, et al. Combined endovascular treatment for both intracranial aneurysm and symptomatic vasospasm. AJNR Am J Neuroradiol. 2003;24:133–9.

    PubMed  PubMed Central  Google Scholar 

  31. ev3. Package insert. In: Occlusion balloon system; 2007.

    Google Scholar 

  32. Hoh BL, Ogilvy CS. Endovascular treatment of cerebral vasospasm: transluminal balloon angioplasty, intra-arterial papaverine, and intra-arterial nicardipine. Neurosurg Clin N Am. 2005;16:501–16. vi

    Article  PubMed  Google Scholar 

  33. Sayama CM, Liu JK, Couldwell WT. Update on endovascular therapies for cerebral vasospasm induced by aneurysmal subarachnoid hemorrhage. Neurosurg Focus. 2006;21:E12.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Harrigan, M.R., Deveikis, J.P. (2018). Endovascular Treatment of Intracranial Stenosis and Vasospasm. In: Handbook of Cerebrovascular Disease and Neurointerventional Technique. Contemporary Medical Imaging. Humana, Cham. https://doi.org/10.1007/978-3-319-66779-9_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-66779-9_10

  • Published:

  • Publisher Name: Humana, Cham

  • Print ISBN: 978-3-319-66777-5

  • Online ISBN: 978-3-319-66779-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics